Emirati Women Chapter Onboards Second Cohort of 62 Participants
Under the patronage of H.H. Sheikha Fatima bint MubarakABU DHABI, United Arab Emirates, April 09, 2025 (GLOBE NEWSWIRE) -- Under...
Month: April 2025
Barbara Weber, M.D., Elected to ITM Supervisory Board
Barbara Weber, M.D., Elected to ITM Supervisory Board Headshot Barbara Weber, M.D. Garching / Munich, Germany, April 09, 2025 –...
ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer
Phase 2 to evaluate safety, tolerability and efficacy of INNA-051 in the prevention of illness due to viral respiratory infectionsStudy...
SBC Medical to Present at the Emerging Growth Conference on April 17, 2025
SBC Medical Group Holdings Incorporated invites individual and institutional investors as well as advisors and analysts, to attend its real-time,...
ValoTx Appoints Marcella Origgi from Johnson & Johnson Innovation as CEO
HELSINKI and NAPLES, Italy, April 09, 2025 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), an immunotherapy company developing novel, adaptable...
Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer
New CCO Joins as Cytosurge Engages in Key Scientific Events Across the USA and BeyondZURICH, Switzerland, April 09, 2025 (GLOBE...
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in...
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from Phase 2 Extension Period...
Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
Saint Herblain (France) and Schlieren (Zurich), April 9, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine...
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors
New Chair brings more than three decades of life sciences industry experience, with a successful track record as a biotech...
The effect of aprocitentan for reducing blood pressure and proteinuria in Black patients with resistant hypertension published in Hypertension
Aprocitentan, on top of background therapy, showed clinically meaningful and durable blood pressure (BP) reduction and a decrease in proteinuria...
US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement
Allschwil, Switzerland – April 9, 2025Idorsia Ltd (SIX: IDIA) today announced that the US Food & Drug Administration (FDA), after...
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company...
Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson’s Disease
HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing...
Myriad Genetics Announces Inducement Awards
SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing...
AMN Healthcare to Hold First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025
DALLAS, April 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss...
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort
-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in third cohort, permitting escalation in next dose concentrationMarlborough, Massachusetts--(Newsfile...
FendX Discusses CDC Recent Reports on the Rise of Antimicrobial Resistance
CDC reports antimicrobial resistance is an urgent global public health threat and, in the U.S., more than 2.8 million antimicrobial...
Fosun Wealth Holdings Strengthens Fintech Strategy as Finloop Becomes a Strategic Enterprise of OASES
HONG KONG, April 9, 2025 /PRNewswire/ -- Finloop Finance Technology Holding Limited ("Finloop"), an AI-driven one-stop institutional wealth management platform...